Concepedia

Chelsea M. Byrd

CM

19

Publications

1.2K

Citations

16

H-Index

1965

Active since

Affiliations

Siga Technologies (United States)(Current)

Oregon State University

United States Department of the Army

Heidelberg University

United States Army Medical Research Institute of Infectious Diseases

Chelsea M. Byrd is an author at Siga Technologies (United States) specializing in medicine, virology, and microbiology.

Top concepts

Publications per year

1965–2014

19

Publications

19

Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246

John W. Huggins, Arthur J. Goff, Lisa E. Hensley et al. · Antimicrobial Agents and Chemotherapy · 2009 · 175 citations · Full text

, , +15

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach et al. · Antimicrobial Agents and Chemotherapy · 2012 · 163 citations · Full text

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

Robert Jordan, Arthur J. Goff, Annie Frimm et al. · Antimicrobial Agents and Chemotherapy · 2009 · 133 citations · Full text

, , +16

Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu et al. · Antimicrobial Agents and Chemotherapy · 2013 · 110 citations · Full text

Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor

Pietro Scaturro, Iuni Margaret Laura Trist, David Paul et al. · Journal of Virology · 2014 · 95 citations · Full text

Rows per page

1–5 of 19